These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8470847)

  • 41. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and long-term effects of antenatal prophylaxis with anti-D immunoglobulin.
    Thornton JG
    Obstet Gynecol Surv; 1991 Feb; 46(2):102. PubMed ID: 1900123
    [No Abstract]   [Full Text] [Related]  

  • 43. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
    Carbonne B; Goffinet F; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
    [No Abstract]   [Full Text] [Related]  

  • 45. Reported management of threatened miscarriage by general practitioners in Wessex.
    Entwistle CC; Bowell PJ; Tovey LAD
    Br Med J (Clin Res Ed); 1987 Oct; 295(6604):998. PubMed ID: 2823956
    [No Abstract]   [Full Text] [Related]  

  • 46. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection and quantitation of fetomaternal hemorrhage.
    Turner WA; Fadel HE; Krauss JS
    South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 52. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-D prophylaxis in 1997: the Edinburgh Consensus Statement.
    James D
    Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F161-3. PubMed ID: 9713023
    [No Abstract]   [Full Text] [Related]  

  • 54. Does Rh-isoimmunization cause early abortion?
    OVERSTREET EW; TRAUT HF
    Am J Obstet Gynecol; 1947 Aug; 54(2):235-41. PubMed ID: 20257308
    [No Abstract]   [Full Text] [Related]  

  • 55. [Transvaginal bleeding in pregnancy, as risk factor of Rhesus-D antigen isoimmunization].
    Hernández-Andrade E; Ahued-Ahued JR
    Salud Publica Mex; 2003; 45(6):492-6. PubMed ID: 14974293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is it always necessary to give anti-D gamma-globulins in the case of spontaneous miscarriage in Rhesus-negative patients?].
    Salvat J; Slamani L; Capilna M; Brescu O
    Contracept Fertil Sex; 1997 Apr; 25(4):V-IX. PubMed ID: 9229512
    [No Abstract]   [Full Text] [Related]  

  • 57. [Erythrocyte immunization in pregnancy].
    Jørgensen FS; Bock JE
    Ugeskr Laeger; 2003 Nov; 165(46):4391-3. PubMed ID: 14655560
    [No Abstract]   [Full Text] [Related]  

  • 58. [What will happen to the Rh prophylaxis?].
    Björnståhl H
    Lakartidningen; 1999 Apr; 96(17):2069. PubMed ID: 10354666
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibody detection after antepartal rhesus prophylaxis: normal values or sensitization].
    Behrens O; Bader W; Holle W; Maas DH; Schneider J
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):342-5. PubMed ID: 8514107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.